A detailed history of Pnc Financial Services Group, Inc. transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 1,000 shares of BDTX stock, worth $2,190. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$2,190
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$2.87 - $4.99 $2,870 - $4,990
1,000 New
1,000 $2,000
Q1 2021

May 07, 2021

SELL
$22.23 - $34.75 $87,141 - $136,220
-3,920 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$29.47 - $35.0 $115,522 - $137,200
3,920 New
3,920 $125,000

Others Institutions Holding BDTX

About Black Diamond Therapeutics, Inc.


  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $79.6M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.